Questel integrates ipQuants' patent co-pilot
Schaffhausen/Paris - ipQuants' software to support the patent process is becoming accessible worldwide through a strategic alliance. Questel, a Paris-based company specialising in intellectual property management, is incorporating ipQuants' patent co-pilot Qthena into its global platform.
Ypsomed invests over 100 million francs in Solothurn
Solothurn/Burgdorf - Ypsomed is to invest 100 million Swiss francs in expanding production capacities for autoinjectors at its Solothurn site. In future, the company plans to focus fully on its insulin pumps and is selling its pen needle and blood glucose monitoring systems businesses to Italy.
Switzerland's Secret as a Global Talent Hub
Switzerland has once again been named the world’s most talent-competitive country. The country offers a high quality of life, including excellent education and employment prospects. Companies benefit from the global talent hubs that are Switzerland and the Greater Zurich Area.
Hemotune raises 14 million Swiss francs
Schlieren - Hemotune has secured investment of 14 million Swiss francs in a Series B2 financing round. The medtech company intends to use the fresh capital to move its blood purification system, the HemoSystem, into clinical trials.
TissueLabs begins biofabrication activities in Bellinzona
Manno/Bellinzona - TissueLabs has secured investment of 800,000 US dollars and has opened a new biofabrication hub in Bellinzona in the canton of Ticino. The fresh capital will help to improve the company’s proprietary technology platforms in addition to establishing strategic partnerships.
Zurich researchers make cancer therapy effective again
Zürich - Researchers from the University of Zurich and University Hospital Zurich have discovered how mutated blood cancer cells can be made to respond to an immunotherapy approach again. Genetically enhanced immune cells used in combination with drugs can eliminate resistance in blood cancer cells.
Biognosys optimizes method for biomarker discovery
Schlieren - Biognosys has improved the plasma proteomics workflows for its TrueDiscovery platform. The new workflows leverage an innovative method for plasma enrichment that captures up to 7000 protein groups in large-scale drug studies and enables a previously unattainable throughput.
dAIgnose helps identify endometriosis
Zurich - Two Zurich-based researchers, via their company dAIgnose, have developed an algorithm that reliably identifies endometriosis on ultrasound images of the womb. This is often difficult to achieve with the human eye alone. It is hoped that the procedure will remove the need for laborious and costly laparoscopy procedures.
Fixposition joins forces with the Chinese firm Autocity
Schlieren/Shenzhen - Fixposition and Autocity have announced a new collaboration. The Vision-RTK 2 positioning sensor developed by Fixposition is to be integrated in the Guangpo autonomous street sweeper from the Chinese manufacturer.
Meet with an expansion expert
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space